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Abstract
IL-1b and IL-18 are proinflammatory cytokines that contribute to renal immune complex disease, but whether IL-1b and IL-
18 are mediators of intrinsic glomerular inflammation is unknown. In contrast to other cytokines the secretion of IL-1b and
IL-18 requires a second stimulus that activates the inflammasome-ASC-caspase-1 pathway to cleave pro-IL-1b and -IL-18
into their mature and secretable forms. As the NLRP3 inflammasome and caspase-1 were shown to contribute to
postischemic and postobstructive tubulointerstitial inflammation, we hypothesized a similar role for NLRP3, ASC, and
caspase-1 in glomerular immunopathology. This concept was supported by the finding that lack of IL-1R1 reduced
antiserum-induced focal segmental necrosis, crescent formation, and tubular atrophy when compared to wildtype mice.
Lack of IL-18 reduced tubular atrophy only. However, NLRP3-, ASC- or caspase-1-deficiency had no significant effect on renal
histopathology or proteinuria of serum nephritis. In vitro studies with mouse glomeruli or mesangial cells, glomerular
endothelial cells, and podocytes did not reveal any pro-IL-1b induction upon LPS stimulation and no caspase-1 activation
after an additional exposure to the NLRP3 agonist ATP. Only renal dendritic cells, which reside mainly in the
tubulointerstitium, expressed pro-IL-1b and were able to activate the NLRP3-caspase-1 axis and secrete mature IL-1b.
Together, the NLRP3-ASC-caspase-1 axis does not contribute to intrinsic glomerular inflammation via glomerular
parenchymal cells as these cannot produce IL-1b during sterile inflammation.
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Introduction
The induction of proinflammatory cytokines is a hallmark of
renal inflammation and initiated by outside–in signaling, e.g. by
activating Toll-like receptors that can convert a wide range of
infectious and non-infectious stimuli into NF-kB signaling [1].
Nuclear translocation of NF-kB induces cytokine mRNA tran-
scription, protein translation as well as immediate secretion of the
cytokine into the extracellular space [2]. Cytokine receptors detect
the cytokine signal and enhance further NF-kB signaling, a process
that leads to rapid amplification of local cytokine production and
the initiation of tissue inflammation and damage [3]. IL-1b and
IL-18 are unique among the proinflammatory cytokines because
they do require two signaling steps: first is the nuclear
translocation of NF-kB to induce the expression of pro-IL-1b
and pro-IL-18 and second is the enzymatic cleavage of immature
cytokines into their mature and biologically active forms [4]. The
enzymatic cleavage of pro-IL-1b and pro-IL-18 involves the
activation of caspase-1 in the intracellular cytosol [4]. The role of
caspase-1 for intrarenal IL-1b and IL-18 processing and
postischemic renal inflammation was documented a decade ago
[5,6], but the triggers for caspase-1 activation remained enigmatic.
The recent discovery of the inflammasomes has provided a novel
concept for the enzymatic cleavage of immature cytokines and
documented its functional importance for a large number of
autoinflamamtory and autoimmune disorders [7]. Inflammasomes
are cytosolic molecules that have the capacity to integrate several
types of danger signals into caspase-1 activation [7]. The NLRP1
inflammasome is activated by Bacillus anthracis lethal toxin and
bacterial peptidoglycans [8,9]. The NLRC4 inflammasome
responds to bacterial flagellin and bacteria containing type III/
IV secretion systems like Salmonella typhimurium and Pseudomonas
aeruginosa [10,11]. The AIM2 inflammasome detects cytosolic
DNA [12]. In contrast to these more or less ligand-specific
inflammasomes, the NLRP3 inflammasome and its adaptor
molecule ASC are known to convert a broad spectrum of
microbial and endogenous triggers into caspase-1 activation [7].
For example, NLRP3 is activated by uric acid crystals, cholesterol
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render NLRP3 activation as a crucial element of a number of
important inflammatory diseases such as gout, atherosclerosis,
amyloidosis and diabetes [13,14,15,16]. Other NLRP3 stimuli
include ATP, oxidative stress or biglycan [17,18,19], which are all
known to contribute to renal cell damage [20,21]. As such it is not
surprising that Nlrp3-deficient mice develop less renal IL-1b-
dependent inflammation after renal artery clamping [22] or after
unilateral ureteral obstruction (UUO) [23]. Given these data we
hypothesized a similar role for NLRP3-ASC-caspase-1 for driving
IL-1b and IL-18 secretion in the glomerular compartment of the
kidney. Some evidence for this concept comes from studies where
IL-1R- or IL-18-deficiency was protective in systemic immune
responses to foreign antigens that had been implanted into the
glomerular basement membrane (GBM), i.e. the autologous
version of anti-GBM nephritis [24,25]. Similar results were
obtained by generating Il-18-deficient MRLlpr mice with sponta-
neous immune complex glomerulonephritis [26]. In both of these
models, glomerulonephritis develops secondary to systemic
immune complex disease, therefore, the role of intrarenal IL-1b
and IL-18 production remains unclear. Direct evidence comes
from LPS-enhanced heterologous anti-GBM nephritis in rats
which were found to be partially protected by anti-IL-1b antibody
treatment [27], but a contribution of NLRP3, ASC, and caspase-1
for intrinsic glomerular inflammation is still speculative. We
decided to use the passive version of nephrotoxic serum nephritis
to induce glomerular inflammation without involving systemic (i.e.
adaptive) immune responses. The disease was induced in wildtype
mice as well as in mice deficient for IL-1R1, IL-18, NLRP3, ASC,
and caspase-1 as an experimental strategy to determine the
functional roles of these inflammatory mediators in glomerular
inflammation.
Results
Heterologous anti-GBM nephritis involves innate but no
adaptive immunity
As the GBM antiserum used here was raised in sheep against
preparations of rat GBM we first examined its nephritogenic
potential in C57BL/6 mice by assessing renal histopathology seven
days after a single intravenous injection of antiserum. Immuno-
staining for sheep IgG revealed a robust positivity exclusively
within the glomerular compartment (Figure 1). In contrast staining
for mouse IgG was negative excluding autologous in situ immune
complex formation against sheep IgG (not shown). Glomerular
pathology was characterized by an expansion of mesangial matrix,
mesangial hypercellularity, focal segmental tuft necrosis, crescent
formation (Figure S1), and glomerular neutrophil infiltrates
(Figure 1). In contrast, glomerular Mac2+ macrophage or CD3+
T cell infiltrates were not detected (not shown). In the
tubulointerstitial compartment focal PAS positive casts were
detected in dilated tubular segments as a sign of massive
proteinuria and tubular atrophy. Glomerular pathology neutrophil
counts were significantly reduced in mice deficient for MyD88, the
main signaling adaptor for Toll-like receptors and IL-1R (Figure 1
and 2). By contrast, proteinuria was not much affected by lack of
MyD88 indicating that the antiserum has MyD88-independent
effects on the glomerular filtration barrier (table 1 and figure S2A).
Rag2-deficient mice displayed the same phenotype as wildtype
mice (Figure 2), indicating that the renal lesions develop
independent of T and B cell immunity. Therefore, we considered
this protocol of heterologous anti-GBM nephritis to be suitable to
study local innate immunity effector pathways in glomerular
inflammation and damage.
Glomerular necrosis and crescent formation involve
interleukin-1
In order to address a putative role of IL-1 and IL-18 in
glomerular inflammation we applied the same disease protocol to
C57BL/6 mice deficient either for the IL-1R or for IL-18. An
assessment of the aforementioned parameters of glomerular
pathology revealed that Il-1r-deficiency partially protected from
segmental lesions (6567% vs. 4766%) and crescent formation
(3262% vs. 2462%) as well as from tubular atrophy seven days
after antiserum injection (Figures 1 and 2A). By contrast, lack of
IL-18 did not significantly protect from glomerular necrosis and
crescent formation, however, tubular atrophy was partially
reduced as compared to wildtype mice (Figure 1 and 2A).
Glomerular neutrophil counts were reduced in IL-1R- but not in
IL-18-deficient mice (Figure 2B). By contrast, proteinuria was not
much affected by the IL-1R genotype (table 1 and figure S2A). We
therefore conclude that IL-1 contributes to glomerular necrosis
and crescent formation and that both IL-1 and IL-18 contribute to
tubular damage.
The NLRP3-ASC-caspase-1 axis is induced in anti-GBM
disease
The secretion of IL-1b involves inflammasome-dependent
activation of caspase-1 [4]. We found pro-IL-1b, caspase-1,
NLRP3 mRNA levels were induced in renal samples of C57BL/
6 mice injected with the GBM antiserum, albeit at an overall low
expression level (Figure 3A). Increase of pro caspase-1 in kidneys
of anti-GBM mice could be also detected on protein level
(Figure 3B). IL-1a and ASC were expressed in kidneys but were
not induced by the GBM antiserum (Figure 3A). The NLRC1,
NLRP4 and AIM2 inflammasome mRNA remained undetectable
at the mRNA expression level (not shown). The intrarenal
expression of NLRP3, ASC, and caspase-1 suggests that they
might be involved in the secretion of IL-1b and inflammation
during anti-GBM nephritis.
Anti-GBM disease develops independent of NLRP3, ASC,
and caspase-1
To determine the role of NLRP3, ASC, and caspase-1 in
glomerulonephritis, we induced heterologous anti-GBM nephritis
in mice with targeted deletions of Nlrp3, Asc, and caspase-1. When
the model was induced following the same protocol as before
Nlrp3-deficient mice displayed an identical phenotype as compared
to wild-type mice in terms of glomerular pathology (Figure 4A) or
glomerular neutrophil infitration (Figure 4C). BUN levels were
increased in Nlrp3-/- mice but this finding did not match with the
renal pathology results. Although this findings exclude NLRP3
activation as a mediator of glomerular damage in this model, IL-
1b secretion could still be mediated through other inflammasomes
that use ASC as a linker for caspase-1 activation [7]. However,
ASC-deficiency did not affect glomerular pathology after GBM
antiserum injection similar to the phenotype observed in Nlrp3-/-
mice (Figure 4A and 4C). Next we studied the role of caspase-1
which is the effector molecule in the inflammasome that cleaves
pro-IL-1b into its active form. As spase-1ca-deficient mice were in a
different genetic background respective wildtype control mice
were also studied. Again, heterologous anti-GBM nephritis
displayed an identical histomorphological and functional pheno-
type in caspase-1-deficient mice as compared to their respective
wildtype controls as assessed by scoring glomerular injury
(Figure 4B), urinary albumine/creatinine ratio and other renal
function parameters (Table 1, figure S2A). This finding was
consistent with no detectable active caspase-1 (p10) in kidneys of
NLRP3 in Glomerulonephritis
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(Figure 3B). Furthermore, cleavage of pro-IL-1b into active IL-1b
(p17) could not at all be detected in kidney isolates, excluding that
other proteases induce IL-1b inside the kidney during heterolo-
gous anti-GBM nephritis (Figure 3B). We therefore conclude that
GBM antiserum induces crescentic glomerulonephritis indepen-
dent of the NLRP3 inflammasome and of ASC-mediated
activation of caspase-1.
Inflammasome activation in isolated glomeruli
Our finding that the NLRP3 inflammasome does not contribute
to glomerular inflammation was unexpected, especially in view of
the recently published data on its role in tubulointerstitial injury
models [22,23]. We therefore questioned whether the cells of the
glomerular compartment are at all able to activate the NLRP3
inflammasome. To address this question we stimulated freshly
isolated glomeruli with LPS or LPS followed by ATP, a potent
Figure 1. Renal histopathology of heterologous anti-GBM nephritis. Kidneys were obtained from wildtype or gene-deficient C57BL/6 mice
on day 7 after saline or antiserum (aGBM) injection. Paraffin-embedded renal sections were stained either with Periodic acid Schiff (PAS) reagent, with
anti-IgG or for neutrophils as indicated. The images show representative glomeruli from at least 5 mice in each group at an original magnification
400x.
doi:10.1371/journal.pone.0026778.g001
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26778Figure 2. Renal phenotype of heterologous anti-GBM nephritis in Rag2-, Il-1r1-, Il-18- and MyD88 deficient mice. A: Morphometrical
assessment of PAS-stained renal sections was performed as described in Methods. WT=wildtype, aGBM=heterologous anti-glomerular basement
membrane nephritis. B: Neutrophil counts per glomerulus in mice from all groups. Values represent means6SEM from 5 mice in each group.
*p ,0.05 versus aGBM WT.
doi:10.1371/journal.pone.0026778.g002
Table 1. Renal function parameters.
No disease Anti-GBM GN
BL6 WT BL6 WT Rag -/- MyD88-/- IL1R1-/- IL18-/- Nalp3-/- Asc-/- NOD/sh NOD/Casp-1-/-
Proteinuria - +++ +++ +++ ++ ++ ++ ++ +++ +++
Plasma BUN 24.6062.62 25.7466.75 26.7764.7 28.9568.1 29.1666.13 30.8266.08 43.7663.8
** 26.8568.5 29.0664.29 33.4765.5
**P,0,01 vs BL6 WT with anti-GBM injection group.
doi:10.1371/journal.pone.0026778.t001
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from the mitochondria of necrotic cells and serves as a potent
agonist of the NLRP3 inflammasome. In bone marrow dendritic
cells LPS stimulation strongly induced pro-IL-1b protein but not
caspase-1 activation and, as expected, mature IL-1b secretion into
cell culture supernatants depended on additional ATP exposure
(Figure 5A, 5C). LPS/ATP stimulation of cultured glomeruli did
not result in an increase of pro-IL-1b protein expression or in
caspase-1 activation (Figure 5C), suggesting that glomerular cells
are unable to secrete mature IL-1b upon ATP exposure.
Inflammasome activation in glomerular cells
Our in vivo data and the lack of IL-1b in glomerular isolates raise
doubts about the functional role of the NLRP3 inflammasome-
mediated caspase-1 activation in glomerular cells. We therefore
examined whether mesangial cells, glomerular endothelial cells
(GEnC), podocytes, and renal dendritic cells are able to mount IL-
1b release. All glomerular cells highly express TLR2 and TLR4.
We prestimulated each of these cell types with TLR4 agonist LPS
or TLR2 agonist Pam3CSK4 and challenged them with the
NLRP3 agonist ATP as done with isolated intact glomeruli. First,
Figure 3. Renal mRNA expression in heterologous anti-GBM nephritis. A: RNA isolates from kidneys of saline- or antiserum-injected C57BL/6
mice underwent quantitative real-time RT-PCR for a number of genes as indicated. Data are expressed as means of the ratio of the specific mRNA
versus that of 18S rRNA 6 SEM. B: Total kidney protein was isolated from saline and GBM antiserum-injected mice after 7 days. Western blot for
caspase-1 illustrates pro caspase-1 at 45 kD and the 10 kD caspase-1 cleaved product which indicates caspase-1 activation. The lower blot shows pro-
IL-1b at 31 kD and mature IL-1b at 17 kD. GAPDH was used as a loading control. Note that heterologous anti-GBM glomerulonephritis is not
associated with caspase-1 activation and IL-1b release. Stimulated bone marrow dendritic cells (LPS/ATP stimulation) served as a positive control. The
increase of pro caspase-1 is quantified by densitometry analysis (ImageJ software).* p,0.05 versus saline control.
doi:10.1371/journal.pone.0026778.g003
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after stimulation. Among all cell types tested only renal dendritic
cells induced IL-1b release (Figure 5, figure S2B). Pro-IL-1b
protein expression, the mature IL-1b form, and caspase-1
activation were assessed by Western blot after 6 hours of
stimulation as before. Consistent with the results from glomerular
isolates LPS did not induce pro-IL-1b protein, IL-1b maturation
or caspase-1 activation in glomerular cells (Figure 5). Obviously,
TLR4 activation does neither induce pro-IL-1b as the necessary
first step for inflammasome–mediated IL-1b release nor did it
activate caspase-1 in mesangial cells, GEnC, and podocytes.
However, renal dendritic cells shared the capacity of caspase-1
activation and IL-1b secretion with BMDCs (Figure 5). We
therefore conclude that inside the kidney immune cells like
CD11c+ DCs are capable of secreting active IL-1b upon
inflammasome activation but this function is not shared by
intrinsic glomerular cells due to an inability to induce pro-IL-1b
upon TLR4 activation or to activate caspase-1 upon ATP
exposure.
Inflammasome activation in isolated glomeruli from Anti-
GBM mouse model
We have shown that glomerular cells are not capable of
processing IL1b, but inflammasome associated genes are upregu-
lated in this mouse model (Figure 3). So we determined the specific
involvement of glomerular and tubulointerstitial comparments in
processing IL1b by isolating glomeruli and tubulointerstitium
(Figure 6A,6B) by paramagnetic glomeruli isolation. We did not
observe any increase in inflammasome associated genes in
glomeruli on day7 (Figure 6A) but tubulointerstitum comparment
showed significant upregulation of proIL1b, procaspase-1, Asc and
Nlrp3 mRNA levels (Figure 6B,6C).
Inflammasome expression in human glomerulopathies
Previously published tubulointerstitial gene expression data
from patients with diabetic nephropathy (DN), focal-segmental
glomerulosclerosis (FSGS), IgA nephropathy (IGAN), and mem-
branous glomerulonephritis were compared to data of non-
progressive proteinuric states such as minimal change disease
(MCD), and healthy controls (living allograft donors, LD).
Consistent with the finding that progressive proteinuric diseases
are associated with tubulointerstitial inflammation, most of the IL-
1 and inflammasome related genes were significantly regulated in
progressive diseases, whereas transcript levels were unchanged in
MCD compared with controls (Figure 7). As CASP1 showed an
induction in all progressive diseases, we further dissected its
expression in glomerular and tubulointerstitial samples of patients
with different progressive glomerulopathies by real-time RT-PCR.
Only in the tubulointerstitial compartment of patients with
systemic lupus erythematosus (SLE), IGAN, and anti-neutrophil
cytoplasmatic antibody (ANCA)-positive, rapidly progressive
glomerulonephritis (RPGN) a significant up regulation compared
to controls could be observed, while in glomeruli no significant
change was seen. Together, genes that are related to the NLRP3-
ASC-caspase-1 axis are induced during progressive glomerulone-
phritis but only in the tubulointerstitium and not in the glomerular
compartment of the kidney (Figure 7).
Discussion
The NLRP3 inflammasome-mediated activation of caspase-1
contributes to a large spectrum of inflammatory diseases but so far
little is known about its role in renal inflammation [28]. We had
hypothesized that glomerular damage would activate glomerular
cells to induce and secrete mature IL-1b and IL-18 by activating
the NLRP3-ASC-caspase-1 axis, a hypothesis not supported by
our results. In contrary, our data show that intrinsic glomerular
inflammation develops independent of the NLRP3-ASC-caspase-1
axis, possibly due to an inability for intrinsic glomerular cells to
induce pro-IL-1b and to activate caspase-1 via NLRP3.
The redundant role of NLRP3, ASC, and caspase-1 in
antiserum induced glomerular pathology was unexpected because
previous studies had documented a non-redundant role of the
NLRP3 inflammasome in two models of renal inflammation. Iver,
et al. reported that Nlrp3-deficient mice are partially protected from
intrarenal cytokine signaling, neutrophil recruitment, and renal
failure associated with postischemic tubular necrosis [22].
Vilaysane, et al. induced tubulointerstitial inflammation by UUO
in Nlrp3-deficient mice and found less tubular damage and
interstitial fibrosis as compared to wildtype mice [23]. The latter
study addressed the contribution of NLRP3 activation in intrinsic
renal cells by experiments with bone marrow chimeric mice and
found that NLRP3 is required in both immune cells and non-
immune cells for the development of tubular damage and
interstitial fibrosis of the same extent as in wildtype mice [23].
Our current study excludes a similar role of NLRP3 in the
glomerular compartment. LPS/ATP was unable to elicit caspase-1
activation and IL-1b release in freshly isolated glomeruli, in
mesangial cells, glomerular endothelial cells, or podocytes while
the same conditions were sufficient to induce IL-1b release in renal
dendritic cells. Isolated glomeruli and tubulointerstitial fractions
form anti-GBM injected mouse supported our finding that IL-1
beta processing in confined to the extra glomerular compartment.
Our data extend on a previous report by Timoshanko, et al. that
concluded from bone marrow chimera experiments with Il-1b-
deficient mice that only leukocyte-derived IL-1b contributes to
autologous anti-GBM nephritis [29]. Altogether, these observa-
tions have two implications: first, intrinsic glomerular cells cannot
secrete IL-1b because they neither induce pro-IL-1b nor do they
activate the NLRP3-ASC-caspase-1 axis; second, normal glomer-
uli harbour negligible numbers of dendritic cells which is
consistent with lineage tracking studies of the mouse kidney [30]
and with immunohistochemical studies of the human kidney [31].
This conclusion is also supported by our human data showing
CASP1 mRNA induction only in the tubulointerstitium, where
most of the NLRP3 inflammasome-related genes are found to be
induced in human nephropathies and where renal dendritic cells
reside [24]. It is intriguing to speculate that the lack of IL-1b
secretion by glomerular cells protects the glomerulus from
inappropriate inflammation potentially induced by immune
complexes, hyperglycemia, oxidative stress, or immunostimulatory
crystals.
The rationale for testing the role of NLRP3-ASC-and caspase-1
was based on the phenotype of Il-1r- and Il-18-deficient mice upon
antiserum injection. However, lack of the IL-1R only partially
reduced glomerular damage. The IL-1R ligates IL-1a in addition
Figure 4. Renal phenotype of anti-GBM nephritis in Nlrp3-, Asc-, and caspase-1- deficient mice. A and B: Morphometrical assessment of
PAS-stained renal sections was perfomed as described in Methods. WT=wildtype, aGBM=heterologous anti-glomerular basement membrane
nephritis. C and D: Neutrophil counts per glomerulus in mice from all groups. Values represent means6SEM from 5 mice in each group. * p,0.05
versus aGBM WT.
doi:10.1371/journal.pone.0026778.g004
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dent IL-1R agonist that contributes to glomerular pathology and it
plays a major role in cell death-induced inflammation [32]. In fact,
IL-1a was shown to contribute to the humoral pathways of
immune complex glomerulonephritis [24]. IL-18-deficiency had
no significant effect on glomerular pathology and only partially
reduced tubular atrophy which may relate to a proinflammatory
role of IL-18 in this compartment. Our data are in contrast to the
documented role of IL-18 signaling in spontaneous lupus-like
immune complex glomerulonephritis of MRLlpr(Fas) mice [26].
Still, glomerular inflammation in heterologous anti-GBM disease
involves innate rather than adaptive immunity given that the
model was MyD88- but not Rag2-dependent. Since injury in this
model was previously shown to involve TLR2 and TLR4 [33,34]
we assume that the TLR2/MyD88 and the TLR4/MyD88
pathways predominate for the induction of innate immunity in this
model of acute glomerulonephritis.
In summary, heterologous anti-GBM nephritis develops inde-
pendently of the NLRP3-ASC-caspase-1 axis likely due to an
inability for glomerular cells to induce and to secrete IL-1b. Renal
dendritic cells secrete IL-1b upon NLRP3 activation mainly in the
tubulointerstitial compartment. We therefore conclude that the
capacity for triggering innate immunity inside the kidney is
compartment-specific. The lack of IL-1b and IL-18 secretion by
glomerular cells is another mechanism that prevents inappropriate
glomerular inflammation and damage.
Materials and Methods
Mice and anti-GBM nephritis model
C57BL/6, NOD/ShiLt, NOD/Casp1-/-, Il-1r1-/-, Il-18-/-,
Myd88-/-, Rag2-/- mice were procured from Jackson Laboratories
(Bar Habour, MA). Nlrp3-/- and Asc-/- mice were generously
provided by J. Tschopp, Epalinges, Switzerland, and by V. Dixit,
Genentech, San Francisco, CA. Mice were housed in groups of 5
mice in filter top cages with unlimited access to food and water.
Cages, nest lets, food and water were sterilized by autoclaving
before use. All experimental procedures were approved by the
local government authorities. 6–8 week old mice were anesthetized
using isoflurane for retro-orbital injection of 100 ml of a anti-GBM
serum (Sheep anti-Rat glomeruli serum procured from Probetex
INC, PTX-001). Urine samples were collected on days 1 and 7
after antiserum injection. On day 7 the mice were sacrificed by
cervical dislocation to collect plasma and kidney tissue. Kidneys
were kept at 280uC for protein isolation and in RNA later
solution at 220uC for RNA isolation. A part of the kidney was also
kept in formalin to be embedded in paraffin for histological
analysis [35]. Urine samples were then analysed for qualitative
estimation of proteinuria by Albustix (Siemens Healthcare
diagnostics, Tarrytown, NY, USA) and quantitative estimation
of albumin (mg/dl)/ creatinine (mg/dl) ratio using mouse albumin
ELISA kit (bethyl laboratories, Montgomery, TX, USA) and
creatinine estimation kit (DiaSys diagnostic systems, Holzheim,
Germany). Plasma samples were analysed for BUN using urea
estimation kit (DiaSys diagnostic systems, Holzheim, Germany).
All experiments were approved by the Ethical Committee of the
‘‘Regierung von Oberbayern’’, Az.: 55.2-1-54-2531-11-10.
Assessment of renal pathology
Renal sections of 2 mm were stained with periodic acid-Schiff
reagent. Glomerular abnormalities were scored in 50 glomeruli
per section by a blinded observer. The following criteria were
assessed in each of the 50 glomeruli and semiquantitatively scored
from 0=absent, 1=mild, 2=moderate, 3=severe, 4=extensive,
respectively: mesangial matrix expansion, mesangial proliferation,
focal necrosis, cellular crescents, periglomerular infiltrate. The
extent of tubular atrophy was scored the same way but only one
score was given per section. Subcapsular and pole-cutted
glomerular cross-sections were ignored. Immunostaining was
performed as described using the following primary antibodies:
for neutrophils (Serotec, Oxford, UK), mouse IgG and sheep IgG
(Caltag Laboratories, Burlingame, CA)[36]. Stained glomerular
cells were counted in 15 glomeruli per section. Rat anti-Mouse Ly-
6B.2 (clone 7/4, Abd serotec) was used as an antibody to
determine neutrophil infiltration.
RNA preparation and real-time quantitative PCR (RT-PCR)
To determine the activation of inflammasome we analyzed the
expression of Nlrp3, IL1b, and caspase-1 by real-time PCR using
the following primers:
Nlrp3: AGAAGAGACCACGGCAGAAG (forw), CTTGGAC-
CAGGTTCAGTGT (rev), IL1a: AGCGCTCAAGGAGAA-
GACC (forw), CCAGAAGAAAATGAGGTCGG (rev), IL1b:
TTCCTTGTGCAAGTGTCTGAAG (forw), CACTGTCAAA-
AGGTGGCATTT (rev), Casp1: TCAGCTCCATCAGCTGA-
AAC (forw), TGGAAATGTGCCATCTTCTTT (rev), Asc: GA-
GCAGCTGCAAACGACTAA (forw), GCTGGTCCACAAAG-
TGTCCT (rev).
Total RNA was isolated from kidneys using Qiagen RNA
extraction kit (Du ¨sseldorf, Germany) following the manufacturer’s
instructions. After quantification RNA quality was assessed using
agarose gels. From isolated RNA, cDNA was prepared using
reverse transcriptase (Superscript II, Invitrogen, and Carlsbad,
CA, USA). Real time PCR was performed using SYBRGreen
PCR master mix and was analyzed with a Light Cycler 480
(Roche, Mannheim, Germany). All gene expression values were
normalized using 18 s RNA as a house keeping gene. All primers
used for amplification were from Metabion (Martinsried, Ger-
many).
Cell culture studies
Bone marrow derived dendritic cells were generated by
established protocols. Glomeruli were isolated from whole kidneys
as described elsewhere [37,38]. Briefly, glomeruli were purified by
applying a paramagnetic isolation method following perfusion of
mice with magnetic 4.5 mm Dynabeads (Invitrogen). Renal
dendritic cells were isolated from whole kidneys by magnetic
beads separation (MACS) using CD11c MicroBeads (Miltenyi
Biotech, Germany). Purity of CD11c positive renal cells was
confirmed by FACS analysis using anti-CD11c antibody (BD
Figure 5. IL-1b release and caspase-1 activation in renal DC, but not in glomeruli and glomerular cells. A. IL-1b release from glomeruli
isolated from healthy C57BL/6 wildtype mice, primary mesangial cells (PMC), podocytes, glomerular endothelial cells (GEnC), and renal dendritic cells
(DC) stimulated with LPS or LPS followed by ATP was measured by ELISA. Bone marrow dendritic cells (BMDC) served as a positive control. Note that
only renal DCs but none of the other glomerular cells released IL-1b after LPS/ATP stimulation. B–D. This was confirmed by Western blot for IL-1b. The
blots illustrate the 37 kDa pro-IL-1b in the upper bands and the 17 kDa mature IL-1b in the lower bands. Western blot for caspase-1 illustrates the
10 kDa caspase-1 cleaved product which indicates caspase-1 activation. GAPDH is shown as a loading control. Stimulated bone marrow dendritic
cells served as a positive control.
doi:10.1371/journal.pone.0026778.g005
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cultured from isolated mouse glomeruli as previously described
[39]. GEnC were cultured the same way [40]. Murine podocytes
were allowed to proliferate in RPMI 1640 medium (GIBCO/
Invitrogen, Paisley, Scotland, UK) containing 10% fetal calf
serum, 100 U/ml penicillin, 100 mg/ml streptomycin (PAA
Laboratories), and 10 U/ml mouse IFN-c (ImmunoTools, Fire-
soythe, Germany) at permissive temperature (33uC), 5% CO2.
Figure 6. Renal mRNA expression in different compartments of kidney in heterologous anti-GBM nephritis. A. inflammasome related
mRNA expression from glomeruli and tubulointerstitial compartments isolated from saline or anti-GBM injected mice on day 7 by using paramagnetic
bead isolation technique as mentioned in the methods. mRNA expression levels of proIL1-b, Nlrp3, Asc, proCaspase-1 and IL1-a from glomerular
compartment (figure A), Tubular compartment (figure B) and flow through fraction which is devoid of tubules and glomeruli (figure C) are shown.
Each analysis represents data from 3 mice in both groups. Microscopic images of glomeruli (figure A) and tubular fraction (figure B) are shown as well.
*P,0.05, **P,0.01, ***P,0.001 compared to saline group.
doi:10.1371/journal.pone.0026778.g006
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PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e26778Cells were differentiated at nonpermissive conditions (37uC), 5%
CO2 without IFN-c supplement for 10–14 days. RPMI 1640
GlutaMAX
TM-I medium (Invitrogen) was supplemented with 10%
FBS and 1% of penicillin and strepto-mycin (PAA Laboratories,
Pasching, Austria). ATP, ultrapure LPS (from Escherichia coli
strain K12) and Pam3CSK4 were purchased from Invivogen, (San
Diego, CA). All cells were stimulated at a density of 1610
6 cells
per ml. Cells were stimulated for 3 hours with LPS (50 ng/ml)/
Pam3CSK4 (1 mg/ml), followed by stimulation with ATP (5 mM)
for 3 hours. Cell-free supernatants were analyzed for cytokine
secretion by ELISA and immunoblot analysis. Cells were lysed for
immunoblot analysis or IL-1b by ELISA according to the
manufacturer’s instructions (BD).
Immunoblot analysis
To identify the activation of the inflammasome in kidney during
heterologus anti-GBM nephritis, we determined the protein
content of pro-caspase-1/caspase-1 and pro-IL-1b/IL-1b in total
kidney 7 days after serum injection by western blots using
antibodies for IL-1b (goat polyclonal anti-IL-1b, R&D Systems,
Minneapolis, MN) and caspase-1 (rabbit polyclonal anti-Caspase-
1sc-514: Santa Cruz, CA, USA). GAPDH (rabbit polyclonal
antibody sc-25778, Santa Cruz Biotechnology) levels were
measured as loading control. Densitometry analysis was performed
with ImageJ software (NIH).
To evaluate the activation selectively in glomeruli, we isolated
protein from glomeruli from saline- and antiserum-injected mice
on day 7 (n=3 in each group). Glomeruli were purified by
applying a paramagnetic isolation method following perfusion of
mice with magnetic 4.5 mm Dynabeads (Invitrogen) as previously
described [37,38]. Cells were lysed in lysis buffer (1% Nonidet P-
40, 50 mM Tris (pH 7.4), 150 mM NaCl) supplemented with a
complete protease inhibitor mixture (Roche), and mixed with
sample buffer [37,38]. At the completion of the 6 hour stimulation
experiment, supernatants, and cells were collected. Supernatants
were concentrated using Amicon Ultra centrifugal filters (Millipore
Billerica, MA) and were resolved on 15% SDS Polyacrylamide
gels. Cells were washed with PBS and treated with NP-40 lysis
buffer (20 mM Tris HCl pH 8, 137 mM NaCl, 10% glycerol, 1%
nonidet P-40, 2 mM EDTA and Protease inhibitors). Protein
concentration of cell lysates was estimated using Bio-rad protein
assay reagent (Bio-rad laboratories GmbH; Munich, Germany).
Cell lysates were subjected to SDS-PAGE gel electrophoresis using
15% acrlyamide gels. About 30 mg of protein was loaded per lane
and after electrophoresis the proteins were transferred to PVDF
membrane. Primary antibodies were goat polyclonal anti-IL-1b
(BAF401: R&D Systems), rabbit polyclonal anti-Caspase-1(sc-514:
Santa Cruz), followed by incubation with secondary antibody anti-
biotin or anti-rabbit IgG labeled with HRP. GAPDH (rabbit
polyclonal antibody sc-25778, Santa Cruz Biotechnology) levels
were measured as loading control. Immunostained bands were
detected using chemiluminescence kit (ECL kit, GE Healthcare,
UK).
Isolation of different compartmental fractions of renal
tissue from saline and anti GBM treated mice
The glomerular fraction was isolated by using magnetic
isolation by perfusion of paramanetic beads. The procedure in
brief is as follow. Animal was anesthetised by intraperitoneal
injection of 2.5% avertin. Animal was then perfused with warm
40 ml PBS containing 8*10
9 magnetic beads (Dnaybeads, M-450
Epoxy) into left ventricle after lancing the vena cava caudalis.
Pressure was maintained at around 60 mm Hg through out the
time of perfusion. Successful perfusion will turn the kidney and
liver pale. After completion of the perfusion kidneys were
harvested and minced into fine pieces. Kidney samples were then
digested with collagenase A for 30 minutes at 37uC. Then the
digested tissue was passed though 100 mm cell strainer on ice.
Then digested and filtered tissue was passed though cell separation
magnet (BD IMagnet, BD) and washed for about 5 times to isolate
glomeruli fractions. First wash elutes tubulointerstitial part of the
kidney. Second wash eluted predominantly the tubular fraction.
Remaining fraction was washed carefully until pure fraction of
90% to 95% of glomeruli was obtained upon microscopic
observation. All the fractions were then lysed using RNA lysis
buffer to prepare mRNA and stored at 220uC until further
procedure.
Human studies
Human renal biopsies from patients and controls were collected
within the framework of the European Renal cDNA Bank -
Kro ¨ner-Fresenius Biopsy Bank [41]. Diagnostic renal biopsies
were obtained from patients after informed written consent and
with approval of the local ethics committees (Die Spezialisierte
Unterkommission- SPUK fu ¨r Innere Medizin, University of
Zurich). Total RNA was isolated from microdissected samples
taken from the tubulo-interstitial compartment. The fragmenta-
tion, hybridization, staining and imaging was performed according
the manufacturer’s guidelines (Affymetrix). For a detailed
description and access to the deposited raw data of the protocol
see reference [42]. A single probe-based analysis tool, ChipIn-
spector (Genomatix Software GmbH, Munich), was used for
transcript annotation, total intensity normalization, significance
analysis of microarrays and transcript identification based on
significantly changed probes [42]. Real-time RT-PCR on biopsies
from independent cohorts of patients with systemic lupus
erythematosus (SLE; n=16), IgA nephropathy (IGAN; n=21),
membranous nephrophathy (MGN; n=17), rapidly progressive
glomerulonephritis (RPGN; n=9) and controls (living donors (LD)
n=7, deceased donor (DD) n=1) was performed. Reverse
transcription and real-time RT-PCR were performed as reported
earlier [41]. Pre-developed TaqMan reagents were used for
caspase 1 (CASP1, NM_033292.2) and the housekeeper gene
GAPDH (Applied Biosystems). Data shown are normalized to
GAPDH and target gene expression in the control cohort is set as
1. The mRNA expression was analyzed by standard curve
quantification.
Figure 7. Expression of inflammasome-related genes in human glomerulopathies. A. Gene expression data were obtained from isolated
tubulointerstitium of patients with diabetic nephropathy (DN), focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IGAN), non-progressive
minimal change disease (MCD), membranous glomerulonephritis (MGN) and controls (pretransplant allograft biopsies) [42,43]. Gene expression of IL-
1 and inflammasome-related genes was significantly regulated in progressive glomerulopathies, but showed no change in minimal change disease
compared to controls. Shown are the fold changes of the transcripts with the highest probe coverage. Quantitative CASP1 mRNA expression was
validated by real-time RT-PCR on microdissected glomeruli (B) and tubulointerstitial compartments (C) from human biopsies of patients with systemic
lupus erythematosus (SLE; n=16), IgA nephropathy (IGAN; n=21), membranous nephrophathy (MGN; n=17), rapidly progressive glomerulonephritis
(RPGN; n=9) and controls (living donors (LD) n=7, deceased donor (DD) n=1). CASP1 showed a significant increase in SLE, IgAN and RPGN patients
compared to controls. * p,0.05, ** p,0.001 versus controls.
doi:10.1371/journal.pone.0026778.g007
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Data are presented as mean 6 SEM. Comparison of groups was
performed using ANOVA and post-hoc Bonferroni `s correction
was used for multiple comparisons. Human data was analyzed
using Kruskall-Wallis and Mann-Whitney U tests (SPSS 17.0,
SPSS Inc., Chicago, IL). A value of p,0.05 was considered to
indicate statistical significance.
Supporting Information
Figure S1 Histopathological assessment of anti-GBM
glomerulonephritis. Kidney tissue was obtained 7 days after
antiserum injection, formalin-fixed, and embedded in paraffin.
Sections were stained with PAS and the respective morphological
characteristics are illustrated by pinpointing those features that
were scored for the semiquantitative assessment. Respective scores
are given in paracenthesis.
(TIF)
Figure S2 A. Proteinuria in anti-GBM GN. Urinary
albumin-creatinine ratios as a marker of proteinuria are shown
from mice of all genotypes. A logarithmic range was used because
all mice with anti-GBM disease developed massive proteinuria in
the nephrotic range. B. No IL-1b release in glomeruli and
glomerular cells. There is no IL-1b release from glomeruli
isolated from healthy C57BL/6 wildtype mice, primary mesangial
cells (PMC), podocytes, glomerular endothelial cells (GEnC)
detectable stimulated with TLR2 agonist Pam3CSK4 or
Pam3CSK4 followed by ATP, measured by ELISA. Bone marrow
dendritic cells served as a positive control (BMDC).
(TIF)
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